Company registration number:
15704565
Iona Therapeutics Limited
Unaudited filleted financial statements
31 May 2025
Iona Therapeutics Limited
Contents
Directors and other information
Statement of financial position and notes to the financial statements
Iona Therapeutics Limited
Directors and other information
|
|
|
|
|
Directors |
Professor Amrita Ahluwalia |
(Appointed 7 May 2024) |
|
|
Professor Anthony Mathur |
(Appointed 7 May 2024) |
|
|
|
|
|
|
|
|
|
Company number |
15704565 |
|
|
|
|
|
|
|
|
|
|
Registered office |
5 Walden Street |
|
|
|
Queen Mary University Enterprise Zone |
|
|
|
London |
|
|
|
E1 2EF |
|
|
|
|
|
|
|
|
|
|
Business address |
5 Walden Street |
|
|
|
Queen Mary University Enterprise Zone |
|
|
|
London |
|
|
|
E1 2EF |
|
|
|
|
|
|
|
|
|
|
Accountants |
Fletcher & Co (UK) Limited |
|
|
|
Staffordshire House |
|
|
|
Beechdale Road |
|
|
|
Nottingham |
|
|
|
NG8 3FH |
|
|
|
|
|
Iona Therapeutics Limited
Statement of financial position
31 May 2025
|
|
|
31/05/25 |
|
|
|
|
|
|
|
£ |
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets |
|
|
20,445 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Creditors: amounts falling due within one year |
|
|
(
20,010) |
|
|
|
|
|
|
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net current assets |
|
|
435 |
|
|
|
|
|
|
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets less current liabilities |
|
|
435 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Accruals and deferred income |
|
|
(
360) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
_______ |
|
|
|
|
|
Net assets |
|
|
75 |
|
|
|
|
|
|
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital and reserves |
|
|
75 |
|
|
|
|
|
|
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
|
Iona Therapeutics Limited
Period ended 31 May 2025
Notes to the financial statements
1.
Directors advances, credits and guarantees
There were no advances to the directors during the period.
For the period ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
-
The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the
board of directors
and authorised for issue on
28 April 2026
, and are signed on behalf of the board by:
Professor Amrita Ahluwalia
Director
Company registration number:
15704565
The company is a private company limited by shares, registered in United Kingdom.